DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Lopes RD, Alexander JH, Al-Khatib SM , et al; ARISTOTLE Investigators.
Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.
Am Heart J 2010;
159 (3) 331-339
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.